ArticleImmunotherapy2025
Poor survival of metastatic cancer patients hospitalized due to immune checkpoint inhibitor-related adverse events.
Veera Nurmela et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it